TITLE

Chronic immune thrombocytopenic purpura-who needs medication?

AUTHOR(S)
Bolton-Maggs, Paula H. B.; Kok, Victoria S. L.
PUB. DATE
July 2010
SOURCE
Annals of Hematology;Jul2010, Vol. 89, p61
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Chronic ITP (immune thrombocytopenic purpura; now defined as duration of more than 12 months) is not always associated with significant bleeding problems so that most children and adults can be managed expectantly with no medication unless surgery, accidents or other pathology mandate it. A cut-off platelet count of 30 x 10(9)/l divides a group with no increased mortality from those whose risk is greater and in whom medication is usually appropriate. There is increasing recognition of long-term morbidity and mortality associated with immune suppression induced by medication and more recently new concerns have arisen about the long-term vascular complications of splenectomy. A more conservative approach to medication is warranted in many patients with chronic ITP.
ACCESSION #
52022221

 

Related Articles

  • Laparoscopic splenectomy for idiopathic thrombocytopenic purpura (ITP). Pace, D.E.; Chiasson, P.M.; Schlachta, C.M.; Mamazza, J.; Poulin, E.C. // Surgical Endoscopy;Jan2003, Vol. 17 Issue 1, p95 

    Background: Although the short-term benefits of laparoscopic splenectomy (LS) have been well documented, long-term follow-up data of patients who have undergone LS for ITP are scarce. We report our long-term follow-up data in patients who underwent LS for idiopathic thrombocytopenic purpura...

  • Management of Immune Thrombocytopenic Purpura in Adults. Stasi, Roberto; Provan, Drew // Mayo Clinic Proceedings;Apr2004, Vol. 79 Issue 4, p504 

    Primary immune thrombocytopenic purpura (ITP), also referred to as idiopathic thrombocytopenic purpura, is an organ-specific autoimmune disorder in which antibodycoated or immune complex-coated platelets are destroyed prematurely by the reticuloendothelial system, resulting in peripheral blood...

  • Diagnosis and management of chronic ITP: comments from an ICIS expert group. Grainger, John David; Bolton-Maggs, Paula H. B.; Godeau, Bertrand; Bussel, Jim; Donato, Hugo; Elalfy, Mohsen; Hainmann, Ina; Matzdorff, Axel; Müller-Beissenhirtz, Hannes; Rovó, Alicia; Tichelli, Andre; Müller-Beissenhirtz, Hannes; Rovó, Alicia // Annals of Hematology;Jul2010, Vol. 89, p11 

    Immune thrombocytopenia (ITP) is a common disorder in children and adults. In a patient with newly diagnosed ITP, the treatment strategy is relatively well defined. Second-line treatments are more controversial, and the management of chronic ITP is even more so. During the 3rd ICIS Expert...

  • Accessory Splenectomy in the Management of Recurrent Immune Thrombocytopenic Purpura. Walters, David N.; Roberts, Jerry L.; Votaw, May // American Surgeon;Nov1998, Vol. 64 Issue 11, p1077 

    Describes a case of recurrent thrombocytopenia associated with an accessory spleen occurring 5 years after splenectomy in a young woman with chronic immune thrombocytopenic purpura (ITP). Causes of failures of splenectomy; Success of accessory splenectomy in producing a sustained remission;...

  • Complement profile in childhood immune thrombocytopenic purpura: a prospective pilot study. Ohali, Meli; Maizlishi, Yair; Abramov, Haya; Schlesinger, Menachem; Bransky, David; Lugassy, Gilles // Annals of Hematology;Dec2005, Vol. 84 Issue 12, p812 

    Immune thrombocytopenic purpura (ITP) is a frequent, usually acute hematologic complication of viral diseases in children. Its evolution is usually benign with spontaneous resolution. Some authors have raised the hypothesis of a possible role of the complement system in the pathogenesis of ITP....

  • Immune Thrombocytopenic Purpura. Cines, Douglas B.; Blanchette, Victor S. // New England Journal of Medicine;3/28/2002, Vol. 346 Issue 13, p995 

    Presents a review that focuses on the diagnosis and management of primary immune thrombocytopenic purpura, an auto immune disorder characterized by a low platelet count and mucocutaneous bleeding. Description of the disorder and its occurrence in children and adults; Possible causes of the...

  • Essential thrombocythemia. Brière, Jean B. // Orphanet Journal of Rare Diseases;2007, Vol. 2, p3 

    Essential thrombocythemia (ET) is an acquired myeloproliferative disorder (MPD) characterized by a sustained elevation of platelet number with a tendency for thrombosis and hemorrhage. The prevalence in the general population is approximately 30/100,000. The median age at diagnosis is 65 to 70...

  • Romiplostim use in ITP. Lohr, Lisa // Hem/Onc Today;12/25/2008, Vol. 9 Issue 23, p13 

    The article discusses the use of romiplostim in the treatment of immune thrombocytopenia or idiopathic thrombocytopenic purpura (ITP). ITP is a syndrome characterized by accelerated platelet destruction. Romiplostim is a recombinant protein that stimulates platelet production by binding to and...

  • Epidemiologic Features and Environmental Risk Factors of Severe Fever with Thrombocytopenia Syndrome, Xinyang, China. Liu, Kun; Cui, Ning; Fang, Li-Qun; Wang, Bing-Jun; Lu, Qing-Bin; Peng, Wei; Li, Hao; Wang, Li-Yuan; Liang, Song; Wang, Hong-Yu; Zhang, Yao-Yun; Zhuang, Lu; Yang, Hong; Gray, Gregory C.; de Vlas, Sake J.; Liu, Wei; Cao, Wu-Chun // PLoS Neglected Tropical Diseases;May2014, Vol. 8 Issue 5, p1 

    Background: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease discovered in rural areas of Central China in 2009, caused by a novel bunyavirus, SFTS virus (SFTSV). The disease usually presents as fever, thrombocytopenia, and leukocytopenia, with case-fatality...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics